Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
Withdrawn

Omalizumab for treating antihistamine-resistant chronic spontaneous urticaria

Condition

Skin

6 February 2026

Published on 02 Jan 2019
Last Updated on 06 Feb 2026

Guidance Recommendations

Omalizumab for treating antihistamine-resistant chronic spontaneous urticaria Guidance is outdated and has been withdrawn on 6 February 2026.

PES Omalizumab for treating antihistamine-resistant chronic spontaneous urticaria(CSU or hives) (Withdrawn 6 Feb 2026) [PDF, 206 KB]

Omalizumab for antihistamine-resistant chronic spontaneous urticaria (Withdrawn 6 Feb 2026)) [PDF, 496 KB]

Back to top